Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,540 | 32,515 | 19,443 | 21,952 | 21,808 |
| Receivables | 10,585 | 9,210 | 9,647 | 10,694 | 10,718 |
| Inventories | 7,683 | 8,796 | 10,085 | 9,534 | 8,753 |
| Other current assets | 1,766 | 2,338 | 1,601 | 2 | 2,174 |
| TOTAL | $37,574 | $52,859 | $40,776 | $44,095 | $43,453 |
| Non-Current Assets | |||||
| PPE Net | 897 | 701 | 824 | 965 | 1,101 |
| Intangibles | 132,043 | 136,387 | 154,458 | 162,344 | 168,867 |
| Other Non-Current Assets | 1,226 | 1,375 | 1,693 | 1,656 | 1,807 |
| TOTAL | $134,166 | $138,463 | $156,975 | $164,965 | $171,775 |
| Total Assets | $171,740 | $191,322 | $197,751 | $209,060 | $215,228 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,345 | 4,692 | 4,692 | 4,692 | 4,692 |
| Accounts payable and accrued liabilities | 13,482 | 12,317 | 13,128 | 14,107 | 14,011 |
| Other current liabilities | N/A | 1,489 | 1,754 | 1,720 | 1,839 |
| TOTAL | $24,091 | $26,120 | $26,194 | $26,688 | $25,303 |
| Non-Current Liabilities | |||||
| Long Term Debt | 63,432 | 77,746 | 79,669 | 82,045 | 85,052 |
| Other Non-Current Liabilities | 735 | 546 | 2,089 | 1,768 | 2,204 |
| TOTAL | $68,320 | $82,496 | $82,491 | $84,675 | $88,123 |
| Total Liabilities | $92,411 | $108,616 | $108,685 | $111,363 | $113,426 |
| Shareholders' Equity | |||||
| Common Shares | 260,595 | 260,595 | 261,359 | 262,127 | 263,586 |
| Retained earnings | -191,157 | -186,313 | -181,078 | -175,457 | -170,935 |
| Other shareholders' equity | -5,016 | -6,174 | -5,211 | -2,838 | -5,024 |
| TOTAL | $79,329 | $82,706 | $89,066 | $97,697 | $101,802 |
| Total Liabilities And Equity | $171,740 | $191,322 | $197,751 | $209,060 | $215,228 |